Pharmacokinetics Study of Oral IXAZOMIB in Participants With Advanced Nonhematologic Malignancies or Lymphoma
Status:
Completed
Trial end date:
2016-06-16
Target enrollment:
Participant gender:
Summary
This is an open-label, multicenter, sequential, 5-arm, phase 1 study of oral IXAZOMIB
designed to assess drug-drug interaction with ketoconazole (Arm 1), the relative
bioavailability of 2 capsule formulations of IXAZOMIB (Arm 2), food effect (Arm 3), drug-drug
interaction with rifampin (Arm 4), and drug-drug interaction with clarithromycin (Arm 5) in
participants with advanced nonhematologic malignancies or lymphoma.